GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 133,000
-1,300 (-0.97%)
Last updated: May 19, 2026, 12:15 PM KST
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.53 trillion as of May 18, 2026. Its market cap has increased by 12.29% in one year.
Market Cap
1.53T
Enterprise Value
2.64T
Revenue
1.99T
Ranking
n/a
PE Ratio
n/a
Stock Price
133,000.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.53T, an increase of 5,169.87%. That is a compound annual growth rate of 13.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.53T | -15.53% |
| Dec 30, 2025 | 1.81T | -11.42% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hanall Biopharma | 2.36T |
| Celltrion Pharm | 2.32T |
| Daewoong Pharmaceutical | 1.67T |
| Chong Kun Dang Pharmaceutical | 1.09T |
| DongKook Pharmaceutical | 1.02T |
| Daewoong | 862.79B |
| Boryung | 834.67B |
| Ildong Pharmaceutical | 727.84B |